ANGELA LYBBERT: Open Payments
NPI 1801907621 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,661 in 81 payments from 16 companies in 2025. Trend: 2023 $956 · 2024 $1,466 · 2025 $1,661
Food & beverage: $1,661
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $493 |
| AstraZeneca Pharmaceuticals LP | 4 | $174 |
| UCB, Inc. | 9 | $168 |
| E.R. Squibb & Sons, L.L.C. | 15 | $141 |
| Amgen Inc. | 7 | $139 |
| SANOFI-AVENTIS U.S. LLC | 4 | $104 |
| Novartis Pharmaceuticals Corporation | 5 | $97 |
| Organon LLC | 5 | $93 |
| ANI Pharmaceuticals, Inc. | 3 | $66 |
| PFIZER INC. | 3 | $57 |
Products named: RINVOQ, Bimzelx, ORENCIA, SAPHNELO, OTEZLA, TZIELD, SKYRIZI, HADLIMA.
Industry payments across NV — which companies pay providers there.
